为维生素K缺乏而产生的新生儿胸膜出血:一个病例报告
Nicole Asdell1, Cecilie Halling1, Susan M Lopata1
1Division of Neonatology, Nationwide Children's Hospital, Columbus, Ohio, USA.
Neonatology
|July 24, 2025
概括
孕产妇克罗恩病可能导致维生素K缺乏,使新生儿和母亲面临严重出血的风险. 早期查和维生素K补充对于高风险怀孕至关重要.
科学领域:
- 新生儿医学 新生儿医学
- 胃肠病学 胃肠病学
- 产科 产科 产科 产科 产科
背景情况:
- 新生儿维生素K缺乏性出血 (VKDB) 是一种可以预防的疾病.
- 孕产妇吸收不良疾病,如克罗恩病,可以损害维生素K的转移,增加新生儿凝血病的风险.
研究的目的:
- 报告新生儿VKDB病例和未被诊断的母亲维生素K缺乏症的次要母性出血.
- 强调查和补充在因吸收不良条件而复杂的怀孕中的重要性.
主要方法:
- 一份病例报告详细介绍了一个早产婴儿,母亲患有克罗恩病.
- 临床表现,实验室发现 (INR,PIVKA-II) 和对母亲和婴儿的治疗干预措施.
- 对婴儿神经发育状况的后续评估.
主要成果:
- 婴儿出现了严重的凝血病和出血的胸膜质量,对维生素K和血有反应.
- 母亲经历了产后出血和凝血病,需要输血和栓塞.
- 母亲和婴儿在服用维生素K后都康复了;婴儿在13个月时有轻微的残留弱点.
结论:
- 在吸收不良疾病的背景下,未被诊断的母亲维生素K缺乏症对母亲和新生儿都构成重大风险.
- 在孕妇患有诸如克罗恩病之类的疾病时,应考虑对维生素K缺乏症进行查和及时补充.
- 积极管理可以防止高风险怀孕的严重出血并发症.
相关概念视频
Vitamins
996
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
996
Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K


